The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
Access restrictions apply.Some or all content stored offsite.
Part II: Subject File, 1902-2012 (continued)
1981 (continued)
(6 folders)
BOX II:181 1982
(1 folder)
BOX II:182 (1 folder)
BOX II:182 1983-1985, 1992-1997, undated
(2 folders)
BOX II:182 National Center for Toxicological Research Protocol Task Force, 1966-1972, 2000
BOX II:182 National Institutes of Health
BOX II:182 National Institute of Mental Health
BOX II:182 Death of subject, 1980-1981, 1997-1999
BOX II:182 Principal Investigators of Early Clinical Drug Evaluation Units, meeting minutes, 1961-1962
BOX II:182 Perinatal study See Container II:196, Foundation for Medical Research Perinatal Study
BOX II:182 Representatives of the U.S. Food and Drug Administration on study sections, 1963-1965, undated
BOX II:182 Neonatal pharmacology, 1960-1982, undated
(2 folders)
BOX II:182 Nester, John O., circa 1992-2000
BOX II:183 New Drug Application (NDA) Preservation Committee
BOX II:183 General, 1962-1964, 1982, 1992-2001, undated
BOX II:183 Lists of NDAs reviewed by Kelsey, undated
BOX II:183 Lists of NDAs (1938-1948) to be transferred to National Archives, Washington, D.C., 1995-1996
BOX II:183 Printout of NDAs approved from 1949, Jan. 1 to 1956, Dec. 31, 1995
BOX II:183 New Drug Evaluation Office, U.S. Food and Drug Administration
BOX II:183 Associate director, 1977-1982, 2001
(2 folders)
BOX II:184 Committee to Update the Management Information System, 1982-1983
BOX II:184 Deputy associate director, 1980-1982
BOX II:184 General, 1976-1983
BOX II:184 Minutes of division director meetings, 1980-1984
(2 folders)
BOX II:184 Project Management Systems, implementation session, 1980
BOX II:184 New uses for approved drugs See Container II:208, “Use of Drugs for Unapproved Indications: Your Legal Responsibility”
BOX II:184 Nishimura, Hideo
BOX II:184 General, 1966-1969, 1976, 1996-2000
BOX II:184 Writings, 1968-1975, 1983
BOX II:184 Nurses’ responsibilities in clinical investigations, undated
BOX II:184 Nutritional aspects, 1968-1974, 1981, undated
BOX II:185 Office of Planning Evaluation, studies, 1978-1981, 1993
(4 folders)
BOX II:185 Omeprazole, 1989-1990, undated
BOX II:185 Organizational Effectiveness Project, 1970, 1981-1982, undated
(2 folders)
BOX II:185 Orphan drugs, 1973, 1982-1983, 1992, 1998, undated
BOX II:186 Oxsoralen (methoxsalen), 1992-1993
BOX II:186 Pediatric labeling rule, draft, 1997
BOX II:186 PEG-Superoxide Dimutase (PEG-SOD), 1993
BOX II:186 Penicillamine, 1969-1971, 1983-1984, undated
BOX II:186 Pentamidine, 1982-1987, 1996, undated
BOX II:186 Pesticides and environmental hazards, 1950-1984, 1996-1998, undated
(4 folders)
BOX II:186 Phase I trials, 1976-1982
BOX II:186 Phenacetin, 1961-1962, 1980, 1996
BOX II:186 Phenformin, 1979-1980
BOX II:187 Placebos, 1950-2000
(2 folders)
BOX II:187 Placental transmission of drugs, 1962-1973, 1979, undated
BOX II:187 Podophyllin, drug deformities, 1962-1963, 1972, 1984
BOX II:187 Poisonous plants and animals, 1955, 1961-2002, undated
(3 folders)
BOX II:187 Poquil, 1953-1956
BOX II:187 Practolol, 1975, 1996
BOX II:187 Prednisolone, 1968, 1997
BOX II:187 Pregnancy and drug metabolism, 1965-1977, circa 1982, undated
BOX II:188 Pregnancy labeling, 1966-1969, 1975-1983, 1997-2001
BOX II:188 Preludin, drug deformities, 1962, 1973
BOX II:188 Primidone See Containers II:128-II:129, Diphenylhydantoin
BOX II:188 Prison studies/testing, 1968-1983, 1991, 1999-2000
(4 folders)
BOX II:188 Privacy Act/Confidentiality statute
BOX II:188 Bioresearch monitoring, 1974-1984
BOX II:188 Statutory protection for medical records, 1977
BOX II:189 Task Force on Health and Medical Records, 1974-1977
BOX II:189 Procaine with polyvinylpyrrolidone (PVP)
BOX II:189 General, 1968-1987, 1995-2000, undated
BOX II:189 Testimony of Kelsey, 1979
BOX II:189 Progestin and other sex steroids, 1942, 1950-2000, undated
(4 folders)
BOX II:189 Prolactin See Container II:116, Bromocryptine
BOX II:189 Proprandol See Container II:98, Antihypertensives
BOX II:189 Propulsid, 2000-2001
BOX II:189 Prostaglandins, 1970-1973, 1984-1985, undated
BOX II:190 Pruzansky, Samuel, 1954-1960, 1967-1969
BOX II:190 Psychotropic drugs, 1962-1984, 1993-2002, undated
BOX II:190 Public Employees Roundtable, photographic slides, 1984
BOX II:190 Quaaludes, 1972-1980, 1996
BOX II:190 Quackery, 1962-1965, 1975, 1989-1999, undated
BOX II:190 Quinine and quinine drugs, 1954-1956, 1964-1972, 1978-1991, 1996-1999
BOX II:190 Radiation, 1929, 1962-1999, undated
(3 folders)
BOX II:190 Radioactive Drug Research Committees See Container II:134, same heading
BOX II:191 Ratner, Herbert, 1962, 1968, 1996-1999
BOX II:191 Regulatory Affairs Professionals Society, 1980, 1990-1997
BOX II:191 Research Testing Laboratories, Inc., Great Neck, N.Y., transcript of conference, 1993
BOX II:191 Retinoids See Containers II:208-II:209, Vitamin D and Vitamin A
BOX II:191 Review Panel on New Drug Regulation, final report, 1977
BOX II:191 Reye’s syndrome See same container, Salicylates
BOX II:191 Rezulin See Container II:156, Hypoglycemic oral agents
BOX II:191 Rounds, 1972-1981, undated
BOX II:191 Royal Society of Medicine, London, England, 1965-1969, 1989, 1996-1999
BOX II:191 Salicylates, 1959-1985, undated
BOX II:191 Schering Corp. See Container II:142, Flunixin
BOX II:191 Schiffirin, M. J., 1965, 1973, 1984, 1998
BOX II:191 Selenium See Container II:206, Toxicology
BOX II:191 Semustine See Containers II:180-II:182, National Cancer Institute
BOX II:191 Separation of functions, 1980
BOX II:191 Serc (Drug), 1968-1969, 1996, undated
BOX II:191 Serotonin, 1963-1964, 1970, undated
BOX II:191 Shepard, Thomas H., Compendium of Teratogens, 1971, 1996
BOX II:192 Shopsin, Baron, 1991
BOX II:192 Sigma Xi, The Scientific Research Society, U.S. Food and Drug Administration club, 1982-1987, 1996-1997, 2012
BOX II:192 Sjoerdsma, Albert, honorary banquet for, 1989
BOX II:192 Society of Nuclear Medicine, 1960-1973, 1998, undated
BOX II:192 Society of Toxicology, 1964, undated
BOX II:192 Special Survey: Sponsors and Investigators of Clinical Investigations, report on
BOX II:192 1970-1980
(6 folders)
BOX II:192 Undated
(1 folder)
BOX II:193 (1 folder)
BOX II:193 Spermacides/trichamonacides, 1972-1986
BOX II:193 Staff College Executive Committee, 1989-1990
BOX II:193 Stem cells, 2000-2001
BOX II:193 Stolpen, Adam, “Allergic Drug Reactions: Where Does the Duty Lie?” circa 1970, 1997
BOX II:193 Straus, Marc J., 1980-1982, 1996-1997, undated
(4 folders)
BOX II:193 Submission management and review tracking, 1995
Next Page »

Contents List